HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma
January 14, 2025
CEO Rob Fried details the production of a supplement that enhances cell repair and energy metabolism, the new normal in healthy aging.